Healthcare Economist November 18, 2021
Jason Shafrin

The answer is ‘yes’, but the magnitude of these savings are relatively small and more than offset by additional OCM program costs. Keating et al. (2021) writes:

In this exploratory difference-in-differences study of Medicare fee-for-service beneficiaries with cancer undergoing chemotherapy (483 310 beneficiaries with 987 332 episodes treated at 201 OCM participating practices and 557 354 beneficiaries with 1 122 597 episodes treated at 534 comparison practices), OCM was associated with a statistically significant relative decrease in total episode payments of $297 that was not sufficient to cover...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Payment Models, Provider, Value Based
Related Articles:
Value-based care adoption is a journey, not a destination. And the map you follow can make all the difference
Ilant Health Secures $5.5M for Value-Based Obesity Management & Cardiometabolic Health
ACOs led by independent physicians save Medicare ‘substantially’ more money, CBO says
Heritage Provider Network: Medical Group, For Sale
CMS to Test Mandatory 5-Year Episode-Based Alternative Payment Model

Share This Article